Molybdenum-99 for Medical Imaging
National Academies Press (Verlag)
978-0-309-44531-3 (ISBN)
Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.
Table of Contents
Front Matter
Executive Summary
Summary
1 Background and Study Task
2 Medical Isotope Production and Utilization
3 Global Production of Molybdenum-99 and Future Prospects
4 Progress Toward Establishing Domestic Production of Molybdenum-99 and Associated Medical Isotopes
5 Progress in Eliminating Highly Enriched Uranium and Remaining Obstacles
6 Molybdenum-99/Technetium-99m Historic and Projected Demand
7 Molybdenum-99/Technetium-99m Supply
References
Appendix A: The American Medical Isotopes Production Act of 2012
Appendix B: Committee and Staff Biographies
Appendix C: Presentations and Site Visits
Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses
Appendix E: Acronyms
1 Front Matter; 2 Executive Summary; 3 Summary; 4 1 Background and Study Task; 5 2 Medical Isotope Production and Utilization; 6 3 Global Production of Molybdenum-99 and Future Prospects; 7 4 Progress Toward Establishing Domestic Production of Molybdenum-99 and Associated Medical Isotopes; 8 5 Progress in Eliminating Highly Enriched Uranium and Remaining Obstacles; 9 6 Molybdenum-99/Technetium-99m Historic and Projected Demand; 10 7 Molybdenum-99/Technetium-99m Supply; 11 References; 12 Appendix A: The American Medical Isotopes Production Act of 2012; 13 Appendix B: Committee and Staff Biographies; 14 Appendix C: Presentations and Site Visits; 15 Appendix D: List of Radiopharmaceuticals and Associated Codes Used in the Committee's Medicare Data and Nuclear Pharmacy Data Analyses; 16 Appendix E: Acronyms
Erscheinungsdatum | 30.11.2016 |
---|---|
Verlagsort | Washington |
Sprache | englisch |
Maße | 152 x 229 mm |
Themenwelt | Medizin / Pharmazie |
ISBN-10 | 0-309-44531-0 / 0309445310 |
ISBN-13 | 978-0-309-44531-3 / 9780309445313 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich